AU2003276187A1 - Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) - Google Patents
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)Info
- Publication number
- AU2003276187A1 AU2003276187A1 AU2003276187A AU2003276187A AU2003276187A1 AU 2003276187 A1 AU2003276187 A1 AU 2003276187A1 AU 2003276187 A AU2003276187 A AU 2003276187A AU 2003276187 A AU2003276187 A AU 2003276187A AU 2003276187 A1 AU2003276187 A1 AU 2003276187A1
- Authority
- AU
- Australia
- Prior art keywords
- pde8a
- therapeutics
- diagnostics
- diseases associated
- human phosphodiesterase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02025000 | 2002-11-08 | ||
| EP02025000.7 | 2002-11-08 | ||
| PCT/EP2003/011876 WO2004042388A2 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003276187A8 AU2003276187A8 (en) | 2004-06-07 |
| AU2003276187A1 true AU2003276187A1 (en) | 2004-06-07 |
Family
ID=32309324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003276187A Abandoned AU2003276187A1 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1604035A2 (en) |
| AU (1) | AU2003276187A1 (en) |
| WO (1) | WO2004042388A2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080548A (en) * | 1997-11-19 | 2000-06-27 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterases |
| US5798246A (en) * | 1996-03-25 | 1998-08-25 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterase |
| US5932465A (en) * | 1997-10-16 | 1999-08-03 | Icos Corporation | Phosphodiesterase 8A |
-
2003
- 2003-10-25 WO PCT/EP2003/011876 patent/WO2004042388A2/en not_active Application Discontinuation
- 2003-10-25 AU AU2003276187A patent/AU2003276187A1/en not_active Abandoned
- 2003-10-25 EP EP03810408A patent/EP1604035A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004042388A2 (en) | 2004-05-21 |
| EP1604035A2 (en) | 2005-12-14 |
| AU2003276187A8 (en) | 2004-06-07 |
| WO2004042388A3 (en) | 2004-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003251471A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) | |
| AU2003276220A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) | |
| AU2003301894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
| AU2003276136A1 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
| AU2003229735A1 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
| AU2003283303A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) | |
| AU2003283427A1 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) | |
| AU2003205627A1 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| AU2003274083A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) | |
| AU2003267380A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) | |
| AU2003294728A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) | |
| AU2003279361A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b) | |
| AU2003276187A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) | |
| AU2003289894A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) | |
| AU2003279323A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) | |
| AU2003288158A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) | |
| AU2003288171A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3) | |
| AU2003282087A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) | |
| AU2003279322A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) | |
| AU2003301913A1 (en) | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) | |
| AU2003274082A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) | |
| AU2003283302A1 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) | |
| AU2003229767A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
| AU2003273994A1 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
| AU2003206749A1 (en) | Diagnostics and therapeutics for diseases associated with the gpr65 receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |